ID

34601

Beschreibung

The I-KAN Study: Internet Insulin Education for Kansans; ODM derived from: https://clinicaltrials.gov/show/NCT01408628

Link

https://clinicaltrials.gov/show/NCT01408628

Stichworte

  1. 19.01.19 19.01.19 -
  2. 17.04.20 17.04.20 -
  3. 18.04.20 18.04.20 -
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

19. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes NCT01408628

Eligibility Type 2 Diabetes NCT01408628

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
Beschreibung

ID.1

Datentyp

boolean

broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
Beschreibung

ID.2

Datentyp

boolean

ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
Beschreibung

ID.3

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of oral glucocorticoids or second generation anti-psychotics;
Beschreibung

ID.4

Datentyp

boolean

previous use of self-administered insulin more than six months prior to enrollment;
Beschreibung

ID.5

Datentyp

boolean

gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
Beschreibung

ID.6

Datentyp

boolean

renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
Beschreibung

ID.7

Datentyp

boolean

pregnant or planning to become pregnant within 6 months;
Beschreibung

ID.8

Datentyp

boolean

hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Type 2 Diabetes NCT01408628

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
boolean
ID.2
Item
broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
boolean
ID.3
Item
ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
use of oral glucocorticoids or second generation anti-psychotics;
boolean
ID.5
Item
previous use of self-administered insulin more than six months prior to enrollment;
boolean
ID.6
Item
gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
boolean
ID.7
Item
renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
boolean
ID.8
Item
pregnant or planning to become pregnant within 6 months;
boolean
ID.9
Item
hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video